These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1416373)

  • 1. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
    Aksit D; Yalinkilinc HS; Sekkin S; Boyacioğlu M; Cirak VY; Ayaz E; Gokbulut C
    BMC Vet Res; 2015 May; 11():124. PubMed ID: 26012791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications.
    Capece BP; Virkel GL; Lanusse CE
    Vet J; 2009 Sep; 181(3):241-50. PubMed ID: 19124257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats.
    Capece BP; Afonso SM; Lazáro R; Harun M; Godoy C; Castells G; Cristòfol C
    Res Vet Sci; 2009 Jun; 86(3):498-502. PubMed ID: 18805559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of albendazole, albendazole sulfoxide and netobimin in goats.
    Benchaoui HA; Scott EW; McKellar QA
    J Vet Pharmacol Ther; 1993 Jun; 16(2):237-40. PubMed ID: 8345574
    [No Abstract]   [Full Text] [Related]  

  • 8. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.
    Delatour P; Garnier F; Benoit E; Caude I
    Res Vet Sci; 1991 Mar; 50(2):134-8. PubMed ID: 2034891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole repeated administration induces cytochromes P4501A and accelerates albendazole deactivation in mouflon (Ovis musimon).
    Velík J; Szotáková B; Baliharová V; Lamka J; Savlík M; Wsól V; Snejdrová E; Skálová L
    Res Vet Sci; 2005 Jun; 78(3):255-63. PubMed ID: 15766946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
    Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI
    J Pharm Pharmacol; 2003 Jun; 55(6):757-64. PubMed ID: 12841935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
    Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen.
    Redondo PA; Alvarez AI; Garcia JL; Larrodé OM; Merino G; Prieto JG
    Drug Metab Dispos; 1999 Jun; 27(6):736-40. PubMed ID: 10348805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single and divided dose administration on the pharmacokinetics of albendazole in sheep and goat.
    Sanyal PK
    Vet J; 1998 May; 155(3):311-6. PubMed ID: 9638078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct separation of albendazole sulfoxide enantiomers by liquid chromatography on a chiral column deriving from (S)-N-(3,5-dinitrobenzoyl) tyrosine: application to enantiomeric assays on plasma samples.
    Lienne M; Caude M; Rosset R; Tambuté A; Delatour P
    Chirality; 1989; 1(2):142-53. PubMed ID: 2642043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.
    Lanchote VL; Takayanagui OM; Mateus FH
    Chirality; 2004 Oct; 16(8):520-5. PubMed ID: 15290687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
    Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
    Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.